Informations générales (source: ClinicalTrials.gov)

NCT02884375 En recrutement IDF
Elderly Cancer Patient: ELCAPA Cohort Survey
Observational
  • Tumeurs hématologiques
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
septembre 2010
novembre 2027
12 septembre 2025
The management of older patients with cancer has become a major public health concern in Western countries because of the aging of the population and steady increase in cancer incidence with advancing age. Cancer treatment of aged patients is complex due to comorbidities, polypharmacy and functional status. The heterogeneity of the older population in terms of comorbidities and functional status may explain the difficulty in establishing management recommendations. Study hypothesis is that a geriatric consultation using Geriatric Assessment (GA) can evaluate patient's resource and strengths, in order to help oncologist to define the most effective treatment. The GA developed by geriatricians and recommended by the International Society of Geriatric Oncology (SIOG), is a multidimensional assessment of general health status; comorbidities; functional status; nutritional, cognitive, psychological, and social parameters; and medications. The GA uses validated geriatric scales to produce an inventory of problems, which can then serve to develop an individualized geriatric intervention plan; it may be an important step in selecting elderly patients for cancer screening and treatment. The objectives are: - To assess the role of GA for decision making process for older patients with cancer - To identify geriatric and oncologic factors associated with overall survival, treatment feasibility, toxicities, morbidities - To develop and/or validate screening tests for frailty in geriatric oncology - To develop and validate frailty classifications Method: The ELCAPA (ELderly CAncer PAtient) survey is a French multicentric prospective study that includes all patients age 70 years or older who has a diagnosis of solid cancer or hematologic malignancies in French hospitals

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
AP-HP Assistance publique - Hôpitaux de Paris En recrutement IDF 18/04/2025 07:56:16  Contacter
AP-HP - Hôpital Dupuytren
AP-HP - Hôpital Lariboisiere-Fernand Widal
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AP-HP - Hôpital Ambroise Paré En recrutement IDF samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Avicenne samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Beaujon samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Bicêtre samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Bichat samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Bretonneau samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Broca-La Rochefoucauld-La Collégiale samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Europeen Georges Pompidou samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Georges Clemenceau samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Henri Mondor-Albert Chenevier samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Louis Mourier samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Saint Antoine samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Saint Louis samedi 13 septembre 2025 Contact (sur clinicalTrials)
AP-HP - Hôpital Tenon samedi 13 septembre 2025 Contact (sur clinicalTrials)
CHI DE CRETEIL samedi 13 septembre 2025 Contact (sur clinicalTrials)
CLCC INSTITUT CURIE samedi 13 septembre 2025 Contact (sur clinicalTrials)
CLCC HOPITAL GUSTAVE ROUSSY samedi 13 septembre 2025 Contact (sur clinicalTrials)
CLCC RENE HUGUENIN INSTITUT CURIE samedi 13 septembre 2025 Contact (sur clinicalTrials)
HU HENRI MONDOR SITE JOFFRE APHP samedi 13 septembre 2025 Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patient aged 70 years or older

- Diagnosed cancer at all stage

- Referred to a geriatrician for GA

- Given oral non-opposition from patient or a legally mandated person



- Oral opposition